Generation of 19bbz CAR-T cells in tcr knockout T-cells

Correia, Eduardo Mannarino; Andrade, Clara; Silva, Leonardo Bastista da; Sessa, Brenno; Abdo, Luiza de Macedo; Hajdu, Karina; Aragão, Emmanuel; Bonamino, Martín Hernan.
No convencional en Portugués | ARCA | ID: arc-58059

Documentos relacionados

  1. High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity.
  2. CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS.
  3. CAR T cells are in it [CD]4 the long haul.
  4. Infusion reactions in natural killer cell immunotherapy: a retrospective review.
  5. Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies.
  6. Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
  7. γδ T cells maintain sensitivity to immunotherapy in MHC-I-deficient tumors.
  8. Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022).
  9. Comparative analysis of cell therapy infusion workflows at clinical sites.
  10. Radiologic Imaging of CAR T-Cell Therapy: Looking under the Hood to Move Us Forward.